Close Menu

NEW YORK (GenomeWeb) – Invitae today announced that it is expecting revenues of more than $144 million in 2018, more than double the revenue it generated in 2017.

As part of a preliminary financials report, the company said it doubled testing volume year over year to more than 302,000 samples compared to around 150,000 in 2017. The revenue projections are approximately $2 million above consensus Wall Street estimates, and testing volume exceeds the company's own prior guidance of 285,000 samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.